RESUMO
The usefulness of a skin test with larval Necator americanus antigen for assessment of hookworm prevalence was evaluated in an endemic area of Costa Rica. In comparison with standard coprologic techniques employed to survey the population, the skin test detected 83% of infections, showing a fairly satisfactory sensitivity. The overall specificity of the test was 50%, i.e., random. No correlation was found between skin reactivity and hookworm burden. The sensitivity of the test increased moderately with age, but its specificity decreased significantly at the same time. False positive reactions were more numerous among persons formerly infected with hookworm who had been negative for as long as 5 years. There was an indication of cross reactivity with intestinal nematodes other than hookworm. The test was used to detect hookworm infected persons in the community for selective treatment, in comparison with mass treatment of all the people in another village. The selective administration of an anthelminthic drug to only skin test positive persons did not achieve the same drop in community hookworm prevalence as did the indiscriminate treatment of the whole population.
Assuntos
Infecções por Uncinaria/diagnóstico , Testes Cutâneos , Adolescente , Adulto , Fatores Etários , Idoso , Ancylostoma/imunologia , Antígenos , Criança , Pré-Escolar , Costa Rica , Reações Falso-Positivas , Fezes/parasitologia , Feminino , Infecções por Uncinaria/tratamento farmacológico , Humanos , Lactente , Larva/imunologia , Masculino , Pessoa de Meia-Idade , Necator/imunologia , Necator/isolamento & purificação , Contagem de Ovos de Parasitas , Tetracloroetileno/uso terapêuticoRESUMO
Mass treatment of a community in Costa Rica with thiabendazole in 1965 reduced the prevalence of S. sterocoralis from 19.2% to 0.3%, and the rates remained low 2 years thereafter. Re-examination of the treated population 7 years after initial treatment showed S. stercoralis prevalence still at a 0.5% level.
Assuntos
Estrongiloidíase/prevenção & controle , Tiabendazol/uso terapêutico , Animais , Costa Rica , Strongyloides/efeitos dos fármacos , Tiabendazol/farmacologiaRESUMO
A new, further attenuated measles vaccine, developed by propagation of Edmonston B measles virus in the chorioallantoic membrane in ovo, has been clinically evaluated in children and found to compare favorably with a commercially available product. The vaccine is prepared in chick embryo tissue culture and appears to possess noteworthy stability at 4 C.